Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.
GLP-1 受體激動劑的心血管保護特性:不僅僅是糖尿病和減重藥物。
J Clin Med 2024-08-29
Beyond the Cardiovascular Effects of Glucagon-like Peptide-1 Receptor Agonists: Body Slimming and Plaque Stabilization. Are New Statins Born?
糖尿病藥物胰高血糖素樣肽-1受體激動劑的心血管效應之外:體重減輕和斑塊穩定。新的他汀藥誕生?
Biomolecules 2024-01-04
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action.
GLP-1受體激動劑在肥胖和2型糖尿病之外對心血管的影響:抗動脈粥樣硬化作用。
Trends Cardiovasc Med 2024-04-23
Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease.
葡萄糖樣肽-1 受體激動劑:治療動脈粥樣硬化心血管疾病的新策略和治療靶點。
Front Pharmacol 2024-05-10